BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $1.63 and last traded at $1.51, with a volume of 46107 shares changing hands. The stock had previously closed at $1.54.
BioRestorative Therapies Stock Performance
The company has a market cap of $2.48 billion, a price-to-earnings ratio of -1.44 and a beta of 102.36. The business’s 50 day moving average price is $1.63 and its 200-day moving average price is $1.59.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Stories
- Five stocks we like better than BioRestorative Therapies
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Find and Profitably Trade Stocks at 52-Week Lows
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- EV Stocks and How to Profit from Them
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
